TAVI sub-studies - Beyond the primary endpoint

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: O. Chehab, B. Hennessey

Speakers: M. Alchay, A. Ielasi, Y. Onuma, P. Serruys, S. Worthley, A. Vora, V. Galli

Summary

This session reviews key sub-studies from major TAVI trials that extend beyond primary endpoints to provide a deeper understanding of valve performance and patient outcomes. It covers comparisons between balloon-expandable and self-expanding valves, long-term real-world data on the Myval valve, echocardiographic outcomes, composite endpoint analyses, and the assessment of coronary artery disease with iFR in TAVI candidates.

Presentations available when logged in:

Balloon expandable vs self-expanding transcatheter heart valves in large annulus: a SWEDEHEART study
Long-term outcomes of Myval transcatheter heart valve series in real-world severe aortic stenosis
One-year echocardiographic outcomes of the Myval vs. contemporary TAVI valves: the LANDMARK trial
Win ratio analysis of the one-year composite endpoints in the LANDMARK trial
One-year full cohort outcomes of TAVI device for low and intermediate risk patients: VANTAGE trial
Five-year outcomes from the SURTAVI and Evolut Low Risk trials stratified by atrial fibrillation
iFR to assess coronary artery disease in patients undergoing TAVI: insights from the FAITAVI trial

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

TAVI sub-studies - Beyond the primary endpoint

Session comprising selected EuroPCR 2026 abstract submissions

Log in or create account for free